DNA Testing Centers Corp. - Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Operating activities:
Net loss	$ (161,287)	$ (101,074)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation	351	545
Stock-based compensation	52,500
Changes in operating assets and liabilities:
Accounts receivable, increase decrease	(2,256)	30
Accounts payable and accrued liabilities, increase decrease	29,757	(12,100)
Net cash used in operating activities	(80,935)	(112,599)
Financing activities:
Repayment of note payable		(4,310)
Proceeds from related parties	83,086	5,780
Proceeds from sale of common stock		53,177
Net cash provided by financing activities	83,086	54,647
Effect of foreign exchange rate changes on cash	1,420	(6,924)
Change in cash	3,571	(64,876)
Cash, beginning of year	207	65,083
Cash, end of year	3,778	207
Supplemental disclosures:
Interest paid
Income taxes paid